Neo-adjuvant Chemotherapy Combined With Stereotactic Body Radiotherapy to the Primary Tumour +/- Durvalumab, +/- Oleclumab in Luminal B Breast Cancer:
Clinical trial NCT03875573 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03875573
- Sponsor
- Jules Bordet Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-06
- Primary completion
- 2025-05-30
- Enrollment
- 147
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.